AI Science Tracker
EN

Division of Medical Oncology

1 discovery from 2023

Discoveries

Study of prevalence and risk factors of chemotherapy-induced mucositis in gastrointestinal cancer using machine learning models.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: The cohort analysis reported toxicity-prediction performance and patient factors associated with mucositis.

Technology: Machine-learning models predicted chemotherapy-induced mucositis and ranked associated risk features in gastrointestinal-cancer patients.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning models predicted chemotherapy-induced mucositis and ranked associated risk features in gastrointestinal-cancer patients.
Limitation / still unknown
Observed patient cohort with model comparisons and toxicity records; prediction is association-based and requires independent prospective validation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1138992/full · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1138992/full#s2 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1138992/full#s3–s4 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1138992/full#s2–s4 · https://pubmed.ncbi.nlm.nih.gov/37841443/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.